Mar 01, 2021 / 09:30PM GMT
Operator
Good day, and welcome to the Inovio Fourth Quarter 2020 Financial Results Conference Call. (Operator Instructions)
Please note, this event is being recorded. I would now like to turn the conference over to Ben Matone. Please go ahead.
Ben Matone - Inovio Pharmaceuticals, Inc. - Director of IR
Thank you, operator. Good afternoon, and thank you for joining the Inovio Fourth Quarter and Year-end 2020 Earnings Conference Call. The call from the company -- on the call from the company are Dr. Joseph Kim, President and CEO; Mr. Peter Kies, Chief Financial Officer; Dr. Jacqui Shea, Chief Operating Officer; Dr. Laurent Humeau, Chief Scientific Officer; Dr. Kate Broderick, Senior Vice President of Research and Development; and Dr. Prakash Bhuyan, Senior Vice President of Clinical Development and Medical Lead for REVEAL 1, the company's Phase III clinical trial for cervical dysplasia.
For today's call, we will review our corporate and financial information for the fourth quarter and full year ended December 31, 2020, as well as provide an update on our
Q4 2020 Inovio Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot